Acytosiosis: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== Acytosiosis == | |||
{{Infobox medical condition | |||
| name = Acytosiosis | |||
| image =[[File:Cytosine-3D-balls.png|alt=Cytosine molecule]] | |||
| caption = 3D model of the [[cytosine]] molecule | |||
| field = [[Genetics]] | |||
| symptoms = [[Developmental delay]], [[intellectual disability]], [[seizures]] | |||
| onset = [[Infancy]] | |||
| duration = [[Lifelong]] | |||
| causes = [[Genetic mutation]] | |||
| risks = [[Family history]] | |||
| diagnosis = [[Genetic testing]], [[clinical evaluation]] | |||
| differential = [[Other genetic disorders]] | |||
| treatment = [[Supportive care]], [[symptomatic treatment]] | |||
| prognosis = [[Variable]] | |||
| frequency = Rare | |||
}} | |||
== Acytosiosis == | |||
[[File:Cytosine-3D-balls.png|thumb|right|3D model of a cytosine molecule, a key component in DNA and RNA.]] | [[File:Cytosine-3D-balls.png|thumb|right|3D model of a cytosine molecule, a key component in DNA and RNA.]] | ||
Latest revision as of 06:06, 4 April 2025
| Acytosiosis | |
|---|---|
| |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Developmental delay, intellectual disability, seizures |
| Complications | N/A |
| Onset | Infancy |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Genetic testing, clinical evaluation |
| Differential diagnosis | Other genetic disorders |
| Prevention | N/A |
| Treatment | Supportive care, symptomatic treatment |
| Medication | N/A |
| Prognosis | Variable |
| Frequency | Rare |
| Deaths | N/A |
== Acytosiosis ==

Acytosiosis is a rare genetic disorder characterized by the absence or severe deficiency of cytosine in the DNA of affected individuals. This condition leads to significant disruptions in cellular function and development, as cytosine is one of the four main bases found in DNA and RNA, alongside adenine, guanine, and thymine (or uracil in RNA).
Pathophysiology[edit]
Cytosine plays a crucial role in the storage and expression of genetic information. It pairs with guanine in the DNA double helix, forming stable hydrogen bonds that are essential for the structure and function of DNA. In acytosiosis, the lack of cytosine disrupts these pairings, leading to instability in the genetic material. This instability can result in errors during DNA replication, transcription, and translation, ultimately affecting protein synthesis and cellular function.
Clinical Manifestations[edit]
Individuals with acytosiosis may present with a variety of symptoms, depending on the severity of the cytosine deficiency and the specific tissues affected. Common clinical features include:
- Developmental delays
- Neurological deficits
- Growth retardation
- Immunodeficiency
- Metabolic abnormalities
The severity of symptoms can vary widely among affected individuals, with some experiencing mild effects and others suffering from severe, life-threatening complications.
Diagnosis[edit]
The diagnosis of acytosiosis is typically made through genetic testing, which can identify mutations in genes responsible for cytosine synthesis or incorporation into DNA. Whole genome sequencing or targeted gene panels may be used to detect these mutations. Biochemical assays can also measure cytosine levels in tissues or bodily fluids, providing additional diagnostic information.
Treatment[edit]
Currently, there is no cure for acytosiosis. Treatment is primarily supportive and focuses on managing symptoms and preventing complications. This may include:
- Nutritional support
- Physical and occupational therapy
- Medications to manage specific symptoms, such as anticonvulsants for seizures
- Regular monitoring and management of metabolic and immunological abnormalities
Research into potential therapies, such as gene therapy or enzyme replacement therapy, is ongoing.
Prognosis[edit]
The prognosis for individuals with acytosiosis varies depending on the severity of the condition and the effectiveness of supportive care. Early diagnosis and intervention can improve outcomes, but the disorder often leads to significant morbidity and can be life-limiting.
